Rohto Pharmaceutical Co.,Ltd.TSE 4527

ロート製薬株式会社 · Pharmaceutical · FY ends Mar

Share price at FY-end
¥2,410
FY ending Mar 2026
Market cap at FY-end
¥569B
Dividend per share
¥46.0
Avg. director pay
¥53.9M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 日本マスタートラスト信託銀行 30,437,000 13.46% ¥73.3B ¥1.4B
2 STATE STREET BANK AND TRUST COMPANY 505223 12,302,000 5.44% ¥29.6B ¥566M
3 日本カストディ銀行 11,139,000 4.92% ¥26.8B ¥512M
4 Yamada Kozan
Asset-management company of Kunio Yamada
8,415,000 3.72% ¥20.3B ¥387M
5 三菱UFJ銀行 7,601,000 3.36% ¥18.3B ¥350M
6 Yamacho Koisan 5,046,000 2.23% ¥12.2B ¥232M
7 日本生命保険 4,238,000 1.87% ¥10.2B ¥195M
8 STATE STREET BANK AND TRUST COMPANY 505001 3,640,000 1.61% ¥8.8B ¥167M
9 Kiyoko Yamada 3,623,000 1.60% ¥8.7B ¥167M
10 ロートグループ従業員持株会 3,062,000 1.35% ¥7.4B ¥141M

Officers' holdings and pay

NameTitleSharesValuePay
Kunio Yamada Chairman & Representative Director 1,181,000 ¥2.8B —
瀬木 英俊 President & Representative Director 14,000 ¥33.7M —
斉藤 雅也 Executive Vice President & Director, CFO 50,000 ¥120M —
國﨑 伸一 Executive Vice President & Director, CTO 45,000 ¥108M —
藤本 陽子 Managing Director, CMO 1,000 ¥2.4M —
河﨑 保徳 Director, CHRO 7,000 ¥16.9M —
山中 雅恵 Director 1,000 ¥2.4M —
本間 陽一 Director 6,000 ¥14.5M —
末延 則子 Director 1,000 ¥2.4M —
入山 章栄 Director — — —
米良 はるか Director — — —
林依 利子 Director — — —
片田 江舞子 Director — — —
岩田 彰一郎 Director 1,000 ¥2.4M —
木村 雅則 Full-time Audit & Supervisory Board Member 62,000 ¥149M —
上村 秀人 Full-time Audit & Supervisory Board Member 12,000 ¥28.9M —
谷 保廣 Audit & Supervisory Board Member 1,000 ¥2.4M —
杦山 栄理 Audit & Supervisory Board Member — — —
寺田 明日香 Audit & Supervisory Board Member — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 ¥2,410 ¥151.56 15.9x ¥46.0 236,178,310
FY ending Mar 2025 ¥2,232 ¥136.11 16.4x ¥36.0 236,178,310
Source: annual securities reports on EDINET. Values are estimates. Methodology